期刊
HEPATOLOGY
卷 62, 期 4, 页码 1304-1312出版社
WILEY-BLACKWELL
DOI: 10.1002/hep.27867
关键词
-
资金
- NCI NIH HHS [R01 CA190176, K08 CA151414, R01 CA152470] Funding Source: Medline
Hepatocellular carcinoma (HCC) is highly associated with inflammation. Myeloid cells, including tumor-associated macrophages and myeloid-derived suppressor cells, are abundant in the HCC microenvironment and are often associated with poor prognosis. Myeloid cells in HCC play a vital role in supporting tumor initiation, progression, angiogenesis, metastasis, and therapeutic resistance. Here, we summarize our current knowledge about myeloid cells in HCC and focus on their immune-suppressive activities and tumor-promoting functions, as well as the relevance to potential new therapies in HCC. (Hepatology 2015;62:1304-1312)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据